AL
BBBY

Aspiriant LLC’s Bed Bath & Beyond Inc BBBY Stock Holding History

Aspiriant LLC’s Portfolio BBBY Stock Details BBBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,250
Closed -$555K – 218
2017
Q2 		$555K Sell
18,250
-16
-0.1% -$578 0.05% 138
2017
Q1 		$721K Sell
18,266
-164
-0.9% -$6.58K 0.06% 131
2016
Q4 		$749K Hold
18,430
– – 0.07% 120
2016
Q3 		$795K Sell
18,430
-4,127
-18% -$183K 0.08% 117
2016
Q2 		$1.55M Buy
22,557
+4,307
+24% +$195K 0.15% 85
2016
Q1 		$906K Buy
+18,250
New +$855K 0.09% 105

Other funds holding BBBY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aspiriant LLC's BBBY Position: Q3 2017 in Review

Aspiriant LLC sold out of Bed Bath & Beyond Inc (BBBY) in Q3 2017, closing a stake of 18,250 shares — an estimated $555K sold.

Aspiriant LLC first reported a position in BBBY in Q1 2016 and held it in 6 quarters. The position peaked at $1.55M in Q2 2016. 366 funds tracked by Wall St. Rank hold BBBY as of Q3 2017.

  • Aspiriant LLC reported no remaining Bed Bath & Beyond Inc position as of Q3 2017 after selling out during the quarter.
  • Aspiriant LLC sold 18,250 Bed Bath & Beyond Inc shares in Q3 2017, an estimated $555K.
  • Aspiriant LLC first reported a position in Bed Bath & Beyond Inc in Q1 2016 and held it in 6 quarters.
  • Aspiriant LLC's Bed Bath & Beyond Inc position peaked at $1.55M in Q2 2016.
  • 366 funds tracked by Wall St. Rank held Bed Bath & Beyond Inc as of Q3 2017.

Based on Aspiriant LLC's 13F filing for Q3 2017, filed 13 Nov 2017.